Onconova Therapeutics Inc. (NASDAQ:ONTX) shares fell 3.8% during trading on Thursday . The stock traded as low as $3.31 and last traded at $3.32, with a volume of 62,944 shares. The stock had previously closed at $3.45.

The company has a 50-day moving average of $4.78 and a 200 day moving average of $4.97. The firm’s market capitalization is $9.15 million.

Onconova Therapeutics (NASDAQ:ONTX) last announced its earnings results on Thursday, May 12th. The biopharmaceutical company reported ($0.27) EPS for the quarter, missing the consensus estimate of ($0.19) by $0.08. Analysts anticipate that Onconova Therapeutics Inc. will post ($7.40) earnings per share for the current fiscal year.

Onconova Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways important to cancer cells. It has three clinical-stage product candidates and many preclinical programs that target kinases, cellular metabolism or cell division.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.